VIM
COLL icon

Vinva Investment Management’s Collegium Pharmaceutical COLL Stock Holding History

Vinva Investment Management’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.31M Buy
24,992
+10,149
+68% +$347K 0.01% 324
2026
Q1 		$693K Buy
14,843
+11,580
+355% +$490K 0.01% 369
2025
Q4 		$230K Buy
+3,263
New +$137K ﹤0.01% 387

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Vinva Investment Management's COLL Position: Q2 2026 in Review

Vinva Investment Management increased its Collegium Pharmaceutical (COLL) stake by 68% in Q2 2026, buying an estimated $347K and bringing the position to 24,992 shares worth $1.31M. The position accounts for 0.01% of the portfolio, ranked #324.

Vinva Investment Management first reported a position in COLL in Q4 2025 and has held it in 3 quarters since. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Vinva Investment Management held 24,992 shares of Collegium Pharmaceutical worth $1.31M as of Q2 2026.
  • Vinva Investment Management bought 10,149 Collegium Pharmaceutical shares in Q2 2026, an estimated $347K.
  • Collegium Pharmaceutical made up 0.01% of Vinva Investment Management's portfolio in Q2 2026, its #324 holding.
  • Vinva Investment Management first reported a position in Collegium Pharmaceutical in Q4 2025 and has held it in 3 quarters since.
  • 279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Vinva Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.